Carlito Lebrilla

Dr. Carlito Lebrilla is a Distinguished Professor at the University of California, Davis, based in Davis, California. Serving across the Department of Chemistry and the Department of Biochemistry and Molecular Medicine, he specializes in analytical chemistry, mass spectrometry, and clinical glycoproteomics. Beyond his academic tenure, Lebrilla has translated his laboratory research into commercial ventures by co-founding three distinct biotechnology and food science startups: Evolve Biosystems, BCD Bio, and InterVenn Biosciences. His entrepreneurial initiatives have attracted substantial venture capital backing, highlighted by InterVenn Biosciences securing a $201 million Series C funding round in August 2021. Additionally, his microbiome company Evolve BioSystems, which later rebranded to Infinant Health, raised a $55 million Series D round in February 2021. His current focus remains centered on bridging academic research with commercial applications to advance clinical diagnostics and biofunctional foods.